Journal of Peking University(Health Sciences) >
Analysis of characteristics related to the disease activity of systemic lupus erythematosus and construction of an evaluation model
Received date: 2024-08-01
Online published: 2024-12-18
Supported by
the National Natural Science Foundation of China(31970648)
Copyright
Objective: To stratify systemic lupus erythematosus (SLE) patients clinically, to analyze the clinical characteristics of patients with and without disease activity, and to explore the application va-lue of key clinical indicators in assessing disease activity, as well as to construct an evaluation model. Methods: A retrospective analysis was conducted on clinical data of the SLE patients diagnosed at Peking University People' s Hospital from May 1995 to April 2014. Demographic information, clinical manifestations, laboratory tests, and antibody detection results were collected. The patients were divided into active and inactive groups based on systemic lupus erythematosus disease activity index 2000(SLEDAI-2000)scores. t-tests, Mann-Whitney U tests, and χ2 tests were used to compare the differences between the groups. Spearman correlation analysis was used to evaluate the relevant clinical indicators associated with SLE activity in the active disease group. Based on the results of statistical analysis, a Logistic regression model was constructed, and the performance of the model was evaluated. Results: No significant differences were found in demographic characteristics between the two groups. In the active disease group, positive rates of antinuclear antibodies (ANA) and anti-double-stranded DNA antibodies (anti-dsDNA) were increased; white blood cell count (WBC), red blood cell count (RBC), hemoglobin (HGB), lymphocytes (LY), total protein (TP), albumin (ALB), and complement 3(C3) levels were significantly decreased; while immunoglobulin A and G levels were markedly elevated. The correlation analysis results showed that hemoglobin, albumin, C3, and complement 4(C4) had higher correlation indices compared with other clinical indicators. Among these, C3 exhibited a certain negative correlation with disease activity. The Logistic regression model based on 12 significantly different indicators (P < 0.05) achieved an accuracy of 91.4%, sensitivity of 94.4%, specificity of 81.0%, and the area under curve (AUC) of the receiver operating characteristic (ROC) was 0.944. Conclusion: This study comprehensively evaluated a range of clinical indicators related to SLE disease activity, providing a thorough understanding of both laboratory and clinical markers. The Logistic regression model, which was primarily constructed using laboratory test indicators, such as inflammatory markers, immune response parameters, and organ involvement metrics, demonstrated a high degree of accuracy in assessing the disease activity in SLE patients. Consequently, this model might provide a new basis for the diagnosis and treatment of SLE patients, offering significant clinical diagnostic value.
Hongyan WANG , Xinming LI , Kechi FANG , Huaqun ZHU , Rulin JIA , Jing WANG . Analysis of characteristics related to the disease activity of systemic lupus erythematosus and construction of an evaluation model[J]. Journal of Peking University(Health Sciences), 2024 , 56(6) : 1017 -1022 . DOI: 10.19723/j.issn.1671-167X.2024.06.011
| 1 | Barber MRW , Drenkard C , Falasinnu T , et al. Global epidemio-logy of systemic lupus erythematosus[J]. Nat Rev Rheumatol, 2021, 17 (9): 515- 532. |
| 2 | Schwartz N , Stock AD , Putterman C . Neuropsychiatric lupus: New mechanistic insights and future treatment directions[J]. Nat Rev Rheumatol, 2019, 15 (3): 137- 152. |
| 3 | Stamm TA , Bauernfeind B , Coenen M , et al. Concepts important to persons with systemic lupus erythematosus and their coverage by standard measures of disease activity and health status[J]. Arthritis Care Res (Hoboken), 2007, 57 (7): 1287- 1295. |
| 4 | Gladman DD , Iba?ez D , Urowitz MB , et al. Systemic lupus erythematosus disease activity index 2000[J]. J Rheumatol, 2002, 29 (2): 288- 291. |
| 5 | Isenberg DA , Rahman A , Allen E , et al. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus[J]. Rheumatology (Oxford), 2005, 44 (7): 902- 906. |
| 6 | Sutton EJ , Davidson JE , Bruce IN . The systemic lupus international collaborating clinics (SLICC) damage index: A systematic literature review[J]. Semin Arthritis Rheum, 2013, 43 (3): 352- 361. |
| 7 | Emamikia S , Oon S , Gomez A , et al. Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus[J]. Rheumatology (Oxford), 2022, 61 (12): 4752- 4762. |
| 8 | Wang Y , Han M , Pedigo CE , et al. Chinese herbal medicine for systemic lupus erythematosus: A systematic review and meta-analysis of randomized, placebo-controlled trials[J]. Chin J Integr Med, 2021, 27 (10): 778- 787. |
| 9 | Chen C , Wang L , Han B , et al. Autoimmune hemolytic anemia in hospitalized patients: 450 patients and their red blood cell transfusions[J]. Medicine (Baltimore), 2020, 99 (2): e18739. |
| 10 | Yin X , Kim K , Suetsugu H , et al. Biological insights into syste-mic lupus erythematosus through an immune cell-specific transcriptome-wide association study[J]. Ann Rheum Dis, 2022, 81 (9): 1273- 1280. |
| 11 | Tobón GJ , Izquierdo JH , Ca?as CA . B lymphocytes: Development, tolerance, and their role in autoimmunity-focus on systemic lupus erythematosus[J]. Autoimmune Dis, 2013, 2013 (1): 827254. |
| 12 | Wang Y , Xiao S , Xia Y , et al. The therapeutic strategies for SLE by targeting anti-dsDNA antibodies[J]. Clin Rev Allergy Immunol, 2022, 63 (2): 152- 165. |
| 13 | Qiu W , Yu T , Deng GM . The role of organ-deposited IgG in the pathogenesis of multi-organ and tissue damage in systemic lupus erythematosus[J]. Front Immunol, 2022, 13, 924766. |
| 14 | Lundtoft C , Sj?wall C , Rantap??-Dahlqvist S , et al. Strong association of combined genetic deficiencies in the classical complement pathway with risk of systemic lupus erythematosus and primary Sj?gren' s syndrome[J]. Arthritis Rheumatol, 2022, 74 (11): 1842- 1850. |
| 15 | Jesus D , Rodrigues M , Matos A , et al. Performance of SLEDAI-2K to detect a clinically meaningful change in SLE disease activity: A 36-month prospective cohort study of 334 patients[J]. Lupus, 2019, 28 (5): 607- 612. |
| 16 | Koo M , Lu MC . Performance of a new instrument for the measurement of systemic lupus erythematosus disease activity: The SLE-DAS[J]. Medicina (Kaunas), 2023, 59 (12): 2097. |
| 17 | 王蒙, 韩迪迪, 王力宁, 等. 系统性红斑狼疮两种评分系统对狼疮肾炎活动临床评价的比较[J]. 中华风湿病学杂志, 2016, 20 (6): 391- 395. |
/
| 〈 |
|
〉 |